In this Q&A, Luke Lindsell, OD, MD, shares his insights on emerging therapies in retina, the evolving role of optometrists in retinal disease management, and the importance of comanagement in patient care.
Wendy Lee, MD, MS, shares how she integrates aesthetic and functional care in oculoplastics.
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.
The new standard: Stabilizing keratoconus and improving vision.
Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.
A machine learning model using treated astigmatism and other nuanced inputs can significantly improve the accuracy and personalization of arcuate keratotomy planning
At the Envision Summit 2025 in San Juan, Puerto Rico, Angela Zhu, MD, offered advice on cataract surgery for all ages, focusing on pediatrics.
Although minimally invasive procedure gives hope, additional research is required.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.
With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
Research can drive opportunities for patients with rare diseases
A powerful conversation about expectations can open communication and trust.
Priorities can ensure optimal outcomes for patients diagnosed with diseases.
Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.
With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
At the Envision Summit 2025 in San Juan, Puerto Rico, Sharon Fekrat, MD, FACS, FASRS talked about multi-modal retinal and choroidal imaging to diagnose and identify neurodegenerative diseases using machine learning.
The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.
Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.
New acrylic implant provides option for patients with endothelial dysfunction.
Presbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.
Studies on nurse-led services find a low level of complications among patients.
Short learning curve, significant clinical advantages make this a comfortable addition.
Early diagnosis of NMOSD is key to preventing disability, improving survival.
During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Ellen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.
A panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.